BRAF Substitution: Intrahepatic Cholangiocarcinoma – 5% ; Extrahepatic Cholangiocarcinoma – 3 %;  Gallbladder Cancer  - 1%. This evidence concerns the gene BRAF and intrahepatic cholangiocarcinoma.